Glenmark Pharmaceuticals released in India the first triple-drug fixed-dose combination (FDC) of the widelyused Teneligliptin with Dapagliflozin and Metformin. This FDC has been launched under the logo name Zita DM, and it carries the DPP4 inhibitor, Teneligliptin (20mg), the SGLT2 inhibitor, Dapagliflozin, (10mg), and Metformin SR (500mg/1000mg) in a hard and fast dose. It should be taken once day by day, below prescription, to enhance glycemic control in sufferers with Type 2 diabetes.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
